Holds 2 active US DMFs for tolvaptan, filing since 2024. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 23 markets.
Holds 2 active US DMFs for tolvaptan, filing since 2013. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 26 markets.
Holds one active US DMF for tolvaptan, filing since 2019. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 30 markets.
Holds one active US DMF for tolvaptan, filing since 2017. Its GMP is recognised in 21 markets.
Holds one active US DMF for tolvaptan, filing since 2025. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 25 markets.
Holds one active US DMF for tolvaptan, filing since 2024. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds 2 active US DMFs for tolvaptan, filing since 2024. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 2 markets.
Holds 2 active US DMFs for tolvaptan, filing since 2019. Its GMP is recognised in 1 market.
This page filters the worldwide Tolvaptan manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for tolvaptan and what filings they hold.
Chat with Fred, your AI analyst